Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.

This study is recruiting. It focuses on bipolarity and currently lists participation information in France.
Leave your email and HopeStage can help you better understand this study.
This study is looking at care and outcomes for people with Schizophrenia or bipolarity. Taking part may give some people access to virtual reality 1, but direct benefit is not guaranteed.
The official record suggests a mix of remote and in-person participation through a research setting, with sites including Services de Psychiatrie I et II - Pôle de Psychiatrie CHRU Strasbourg. Participation appears to involve assessments along with scans or samples to help researchers understand patterns more clearly. The main fit is usually being able to understand the study and consent, while common reasons not to take part include active substance or alcohol problems that could affect the results. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
This study may matter because it is evaluating virtual reality 1, virtual reality 2 in a structured research setting. For people exploring bipolarity research, clear information about the goal, status, contacts, and official source can support better questions before any decision.
Taking part may help test a support approach in real life.
It requires regular visits and structured follow-up.
Mixes in-person and remote participation.
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
This study is exploring behavioral or lifestyle intervention for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
This study is sponsored by Institut National de la Santé Et de la Recherche Médicale, France. Based on the sponsor name or official registry information, it appears to be a research institute. You should verify the details in the official registry record.
This study may involve behavioral or lifestyle intervention, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me